Our findings confirm previous reports [29], [39], [55] and further suggest that haploinsufficiency of DGCR8 could alter the miRNA expression landscape and contribute to the wide clinical phenotype, including cognitive, neurocognitive, psychiatric disorders and cardiac disease, observed in 22q11DS. This evidence concerns the gene DGCR8 and 22q11.2 deletion syndrome.